M2 Peptide

M2 peptide is an M2 tumor-associated macrophage-targeting peptide. It has been used in the generation of anticancer polymeric micelles encapsulating the STAT6 inhibitor AS1517499 (Cay-29071) for delivery to M2 tumor-associated macrophages (TAMs) in vitro and in vivo. Cayman's M2 Peptide is intended for use in peptide conjugation to lipid-based drug delivery platforms containing maleimide-activated lipids such as DSPE-PEG(2000) maleimide (Cay-34272) for TAM-targeting applications.Synonyms: M2pep, TAM-targeting Peptide. MW: 1,757.7. Formulation: (Request formulation change), 1 mg of a lyophilized peptide trifluoroacetate salt. Peptide Sequence: YWWKVGWPDQEYC-NH2.